COCM
TTOO

Charter Oak Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Charter Oak Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 947
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1044
2022
Q1 		$2K Hold
1
– – ﹤0.01% 906
2021
Q4 		$2K Hold
1
– – ﹤0.01% 793
2021
Q3 		$3K Hold
1
– – ﹤0.01% 736
2021
Q2 		$4K Buy
+1
New +$6.46K ﹤0.01% 700

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charter Oak Capital Management's TTOO Position: Q3 2022 in Review

Charter Oak Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q3 2022, closing a stake of 1 share.

Charter Oak Capital Management first reported a position in TTOO in Q2 2021 and held it in 5 quarters. The position peaked at $4K in Q2 2021. 54 funds tracked by Wall St. Rank hold TTOO as of Q3 2022.

  • Charter Oak Capital Management reported no remaining T2 Biosystems, Inc position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 1 T2 Biosystems, Inc share in Q3 2022.
  • Charter Oak Capital Management first reported a position in T2 Biosystems, Inc in Q2 2021 and held it in 5 quarters.
  • Charter Oak Capital Management's T2 Biosystems, Inc position peaked at $4K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.